Status:
RECRUITING
Perinatal Transmission of MDR Bacteria
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
E. Coli Infection
Multi-antibiotic Resistance
Eligibility:
FEMALE
Brief Summary
The investigators aim to conduct a prospective surveillance study of mothers and their infants born vaginally or by scheduled C-section and who are admitted to Northwestern Medicine Prentice Women's H...
Detailed Description
The rapid rise of multi-drug resistant Enterobacteriaceae (MDR-E) is severely threatening the way we treat common infectious diseases. A particularly vulnerable population are neonates where a delay i...
Eligibility Criteria
Inclusion
- Women that are admitted to Northwestern Medicine Women's Hospital that have delivered an infant vaginally or have had a scheduled C-section without preceding labor.
- Infants that are born vaginally who are healthy and do not require transfer to the NICU for any reason.
Exclusion
- Temperature \>38 Celsius in labor
- Caesarean section after labor
- Rupture of membranes or done emergently
- Antibiotic use in last trimester including for GBS+
- Delivery at \<35 weeks
- Immunocompromised host including being HIV+
- Infant requiring transfer to NICU for any reason and infants who are transferred to the NICU.
Key Trial Info
Start Date :
July 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06148480
Start Date
July 17 2020
End Date
December 31 2026
Last Update
January 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prentice Women's Hospital
Chicago, Illinois, United States, 60611